ERCC2 and cancer: Aside from the hypomorphic mutant forms of human XPD, we also tested one null mutant and two frequently occurring polymorphisms, D312N and K751Q, that have been studied intensively for their possible association with cancer susceptibility (reviewed in Clarkson and Wood, 2005; Manuguerra et al., 2006).